Showing posts sorted by date for query chandler. Sort by relevance Show all posts
Showing posts sorted by date for query chandler. Sort by relevance Show all posts

Tuesday, October 20, 2026

A Texas Judge Ordered Air Conditioning in Every Prison: Florida’s Case Is Next


FacebookTwitter

 October 19, 2026



In the dorms, there’s a water fountain, but it’s always warm because many mouths are slurping the cold water greedily. Sweat beads off the dorm’s sticky walls. Men pass out on their racks when the heat overcomes them. At Lawtey CI, they brought a stretcher to carry men out. It’s 90 degrees outside, plus the Florida humidity, and it’s routinely over 100. Floridians are used to the sweltering heat.

This is different.

The dorms I lived in were open-bay, housing 80 to 120 men in a single room. A hundred-plus men, without AC. Our own body heat was part of the equation.

Confinement is worse. Confinement is where you feel as if you’re your own puddle of sweat on the floor, with a metal sink attached to the toilet, where we’d sip water like we’re fish trying to breathe out of the water.

I served eight and a half years in the Florida Department of Corrections, from 2010 to 2018, at Lake Butler RMC, Suwannee CI Annex, Taylor CI Main Unit and Annex, Lawtey CI, and Baker CI. CI stands for correctional institution, which is what Florida calls most of its prisons. Florida State Prison is the only major institution with “prison” in its name. I’ve been home for eight years now. In September, a federal judge in Texas ruled that holding prisoners in extreme heat without air conditioning is unconstitutional, and in Florida, a lawsuit over the heat in one prison, whoops, “Correctional Institution,” is headed to trial in Miami.

On September 22, U.S. District Judge Robert Pitman ordered Texas to air-condition every one of its prisons by the end of 2029. He found that at least nine people died from the heat in Texas prisons between 2023 and 2025, and he wrote that even without deaths or injuries, the extreme heat “creates degrading, inhumane conditions and causes severe suffering.”

His order covers about 90,000 people, nearly two-thirds of the state’s prisoners. Texas has required its county jails to stay at 85 degrees or below since 1994, but it never required that of its prisons. The case started with Bernie Tiede, the man Jack Black played in the movie “Bernie,” who suffered a stroke in the summer of 2023 in a cell that court documents say regularly exceeded 110 degrees. Texas has appealed to the conservative Fifth Circuit and asked Pitman to put his order on hold. In an October 8 filing, the state said enforcing it before the appeal is decided would throw “chaos and confusion” into its plans to install air conditioning. The agency says it will cool every prison, but it hasn’t set a date.

Florida’s in a different federal circuit. The Eleventh Circuit hears federal appeals from Florida, Georgia, and Alabama, and it has already decided a prison heat case.

Men on Florida’s death row at Union Correctional Institution sued over the heat in their cells. In 2004, the court ruled against them, upholding a finding that the temperatures there were “almost always consistent with reasonable levels of comfort and slight discomfort”, the kind anyone would expect in a Florida home without air conditioning. The court wrote that “a prisoner’s mere discomfort, without more,” isn’t enough to violate the Eighth Amendment. That case is Chandler v. Crosby. As of 2024, the Eleventh Circuit still hadn’t found excessive heat in a prison to be cruel and unusual punishment.

In 2022, the Florida Department of Corrections said only 157 of its 639 dorms had air conditioning.

The case that could change that is Wilson v. Dixon. In October 2024, the Florida Justice Institute sued on behalf of the men at Dade Correctional Institution, a concrete prison in Homestead, less than six miles from Everglades National Park, where none of the dorms are air-conditioned. The lawsuit says the heat likely contributed to four deaths. In September 2025, U.S. District Judge Kathleen Williams let the men sue as a class, on behalf of every man held there now or in the future. This May, Florida asked her to undo that, and she hasn’t ruled. The class covers about 1,400 men, and Dante Trevisani, litigation director at the Florida Justice Institute, told me that “as of now, we plan to be ready to go to trial starting November 2nd,” though he said he can’t predict whether the judge will push it back.

Stefano Schiavon, a UC Berkeley professor of architecture and civil and environmental engineering, used 31 sensors installed throughout Dade CI to measure the heat there in the summer of 2025. “At every location, it was hotter inside the prison than it was outside,” he said. In some wings, the heat index was above 88 degrees 97 percent of the time. The median was 98, with peaks around 120.

I never did any time at Dade CI, but I lived in that heat for multiple summers, and it was brutal inside those dorms, where we sweated through the night.

When the men sued, Florida asked the judge to throw the case out. The Constitution, the state’s lawyers wrote, “does not mandate comfortable prisons.” The state also pointed to the posters it had put up about heat-related illness as evidence it was responding reasonably.

The Miami Herald reported that Florida’s DOC doesn’t keep track of heat deaths. Every death gets recorded as a homicide, a suicide, an accident, or natural.

The men’s lawyers have a medical doctor and a forensic pathologist who looked at the deaths in the lawsuit and the heat those men were exposed to. Their opinion, Trevisani said, is that “the heat was a contributing factor to their deaths,” a cause the DOC doesn’t record.

In 2012, the year I worked in the infirmary at Lake Butler, Florida called 298 of its 324 prison deaths natural. That’s 92 percent. At Lake Butler RMC, it was 172 of 176. The department’s own page said its counts cover “the previous 5 fiscal years,” so the oldest ones fell to the wayside every summer. I wrote about them in October. How many of these deaths were due to the heat? We’ll never know.

It’s a double-edged sword, the heat and the cold.

Suwannee CI Annex in Florida, where I was housed during the summer of 2012, is what we call a climate-control camp, which inside the prison walls means air conditioning. When Florida says it, it means something else. “Various climate control measures are used to reduce heat, including industrial fans,” the department says about the dorms it doesn’t cool. At the correctional institutions I did time in, those fans were there to pull stale air out of the dorm and not to cool it down in the least.

On the department’s own list of facilities with air conditioning, the Suwannee Annex was one of only 10 prisons that weren’t marked “partially” air-conditioned. Where I was in confinement, the AC there became a torture device. The officers would turn the temperature of the wing down so low, and sometimes strip you of your clothes and bedding, leaving you alone to do as many jumping jacks and exercise as you could, only for a moment, to curl yourself upon your lap on the toilet praying for a wink of sleep, which was nearly impossible. When the lights turn on at 4:00 a.m., if you have a bed to make (unless you’re on property strip, when they’ve taken everything), you make it, and then your teeth chatter for hours. All I had on were white boxer shorts that barely stayed on, because they gave me a pair that didn’t fit.

My Department of Corrections record shows I went into confinement at the Annex on July 25. Outside, it was a Florida July. Inside, I was shivering.

Florida’s federal courts have looked at that too. In December 2011, at Santa Rosa Correctional Institution, an officer turned off the heat during the day in a dorm where a man was being held without his property, in a cell with a window that wouldn’t completely close. He sued. In 2017, the court ruled that turning off the heat, combined with the man’s lack of property, wasn’t “an extreme deprivation.”

That same department ran the air conditioning on my confinement wing cold enough to keep a man in his boxers awake in July.

In Texas, Judge Pitman called it “deliberate indifference” that the prison director failed to commit to a plan to install air conditioning on a timeline the agency itself had said more than once was possible. In Florida, the state has asked Williams to decide the case without a trial, arguing that the evidence doesn’t show the conditions at Dade CI are unconstitutional. Trevisani called the Texas ruling “persuasive, we think,” even though it came from another circuit. If the men win, he said, the remedy they’ll argue for would be “something that lowers the heat index to some kind of safe level,” and only at Dade, since the case doesn’t reach any other prison.

The Florida Department of Corrections calls itself “the nation’s third-largest prison system” in its own annual report, and its lawyers wrote “prisons” in front of Williams, so even Florida forgets what it calls its correctional institutions.

Comfort was never the issue inside Florida’s prisons—”Correctional Institutions”—but control sure is.

Emmett Tatter is a writer, prison reform advocate, and certified yoga teacher based in Saint Augustine, Florida. He served a ten-year sentence in the Florida Department of Corrections and lectures on mental health, addiction, and criminal justice at colleges including Flagler College and St. Mary’s College of Maryland. His memoir COUNT TIME was named first runner-up for the 2026 Killer Nashville Claymore Award for Best Nonfiction, and it’s represented by Kristen Terrette at Martin-Newens Literary Management. It carries endorsements from NYT bestselling author Les Standiford, Dr. Baz Dreisinger (founder and executive director of Incarceration Nations Network), former Chief Judge Pamela L. North, former CNN editor John DeDakis, international yoga teacher Jared McCann (2013 world asana champion), and others. Two of his essays have been accepted for publication in Inquest.

Friday, August 21, 2026

RIGHT TO LIFE

With three prisoners scheduled for execution, southern churches toll their bells

(RNS) — Faith-based anti-death penalty activists have used the bell-tolling tactic throughout the country in various waves.
Kristen Hansen, minister of music, rings a bell in opposition to the death penalty outside First Evangelical Lutheran Church, Thursday, Aug. 13, 2026, in downtown Nashville.        (Photo courtesy of Death Penalty Action)

“ We have to be together in our opposition to executions and in our statement that this is not in alignment with the teachings of our faiths,” Abraham Bonowitz, the executive director of Death Penalty Action and co-founder of L’chaim! Jews Against the Death Penalty, told RNS. “ There should never be an execution without protest.”

On Thursday morning (Aug. 13), Tennessee executed Anthony Darrell Hines and Oklahoma executed Carlos Cuesta-Rodriguez. Alabama is scheduled to execute Jeremy Williams Thursday evening. All three were convicted of murder.

Last year saw a surge in executions, with 47 people put to death, more than any year since 2009.

The faith-based effort to toll church bells is a revival of a campaign originally inspired by Filipino Cardinal Jaime Sin’s 1983 order that Catholic churches ring their bells to call for an investigation into the assassination of opposition leader Benigno Aquino Jr., which opposition leaders claimed was ordered by President Ferdinand Marcos.

In 1999, Catholic Bishop Walter Sullivan of Richmond, Virginia, asked churches in his diocese to toll bells on the evening of an execution.

Abraham Bonowitz, of the group Death Penalty Action, leads a demonstration outside the Capitol in Montgomery, Ala., on Monday, June 8, 2026, to oppose an upcoming execution in Alabama. (AP Photo/Kim Chandler)

Faith-based anti-death penalty activists have since used the tactic throughout the country in various waves, but today is the first widespread bell tolling since Death Penalty Action took up the campaign, Bonowitz said.

In the 50 years since a Supreme Court decision reignited the modern era of the death penalty in the United States, faith-based opposition has been a cornerstone of successful abolition and commutation campaigns — even as religious Americans as a whole tend to support the death penalty, data suggests. 



In addition to the bell-ringing campaign, called For Whom the Bells Toll, Death Penalty Action hosted a virtual vigil, which included recordings of “El Malei Rachamim,” a Jewish prayer for the dead, and Psalm 23 by Cantor Michael Zoosman, an anti-death penalty activist.

Last weekend, activists with Death Penalty Action marched from Riverbend Maximum Security Institution, where Tennessee’s men’s death row is housed, to the state Capitol to call for the abolition of the death penalty.

In downtown Nashville on Thursday, First Evangelical Lutheran Church rang a bell provided by Death Penalty Action because the church does not have its own bell. That bell, created by Delaware Citizens Opposed to the Death Penalty, tolled outside as Delaware prisoners were executed in the 1990s and 2000s, until the state ended executions. Since then, it has been rung in opposition to the death penalty in more than a dozen states, according to Death Penalty Action.

Demonstrators stand in the area reserved for people opposed to the death penalty as guards on horseback are positioned nearby outside Riverbend Maximum Security Institution before the planned execution of Anthony Darrell Hines, Thursday, Aug. 13, 2026, in Nashville, Tenn. (AP Photo/Mark Humphrey)

The Rev. Travis Meier, the church’s pastor, told RNS the decision to toll the bell was inspired by 1 Corinthians  15:26,  ”The last enemy to be destroyed is death.” Meier said the death penalty is another way “ we have mechanized death as a society.”

Meier entrusted his music director to ring the bell as he went to Riverbend Maximum Security Institution to attend a prayer vigil that local activists hold outside executions.

On Wednesday, Dan Mann, a Christian who regularly visits a man on death row there, told RNS that he planned to be present for that vigil. Mann said that he regularly talks to other men in the visitation room and that he met Hines once.

Of the men he sees more often, he said, “ We tell them about our life and what we have going on. They tell us about theirs. And in all of that, we’ve become very close,” Mann said.

Inspired by Matthew 25, Mann and his wife, Bethany, have been visiting death row since 2010. In years when there are many executions, the prisoners become especially “somber” and reflective about their childhoods, he said. 

Growing up a fundamentalist Christian, Mann said he was taught that “ if you killed somebody, you deserved to die.” But he now believes that people on death row “are not the people that were put in there 40 years ago,” leading him to conclude that “there is nobody out of the reach of God’s mercy.”

Now, Mann attends Christ Church Cathedral, an Episcopal church that joined other downtown Nashville churches in asking Gov. Bill Lee to stay Hines’ execution. The governor declined to intervene earlier this week. 

Christ Church Cathedral also committed to toll its bells. The five pastors who signed a letter about it wrote, “The bells will toll for mercy, remembering the words of Scripture: ‘Mercy triumphs over judgment.’”



At the vigil outside the prison, after an opening prayer and reading scripture together, the group of a couple dozen waited for news that Hines had been executed, Meier said.

During that time, “ I pray, and I walk because I can’t sit still,” Meier said. His prayers are for Hines, his victim and her family, the prison staff and for a change of heart among legislators.

On Thursday, Meier said, the somber gathering also grappled with “frustration” over Tennessee’s most recent botched execution attempt, during which a doctor spent over an hour trying to insert an IV line to execute Tony Carruthers. Witnesses say the attempt created excruciating pain for Carruthers, who has now been spared execution for a year.

Unlike that last vigil, this time, faith leaders received news that Hines had been successfully executed. The faith leaders sang “Amazing Grace” and prayed the Commendation of the Dying, Meier said.

Meier lamented “the system of death” in the U.S. “ That three executions can happen in the same day, and a majority of the population have no clue that it’s happening — it’s just so commonplace that nobody bats an eye,” he said.

Tuesday, August 18, 2026

 

Immunotherapy found effective against a subtype of difficult-to-treat ovarian cancer



IL-17*¹-based prediction of treatment response may advance personalized medicine




Kindai University

Research Overview 

image: 

IL-17 acts directly on the cancer cells and creates an immune-permissive tumor microenvironment by recruiting immune cells.

view more 

Credit: Dr. Kosuke Murakami from Kindai University, Japan





A research group led by Kosuke Murakami, Lecturer in the Department of Obstetrics and Gynecology, Kindai University Faculty of Medicine (Sakai City, Osaka Prefecture), and Professor Noriomi Matsumura, Head of the Department, together with collaborators including Shiki Takamura, Team Director of the Laboratory for Immunological Memory, RIKEN Center for Integrative Medical Sciences (Wako City, Saitama Prefecture), and the Department of Immunology at Kindai University Faculty of Medicine, has revealed, through studies in both humans and mice, that a subset of clear cell ovarian cancers*2, which has been considered difficult to treat with anticancer drugs and immunotherapy, contains a type that responds to immunotherapy. They also identified inflammation-related protein IL-17 as a key factor underlying this response. The study also discovered that IL-17 acts directly on the cancer cells and creates an immune-permissive tumor microenvironment by recruiting immune cells. Harnessing this mechanism may enable prediction of immunotherapy efficacy in individual patients, contributing to the development of personalized medicine.

The provisional version of the research article was published on June 30, 2026, and the final version was published on July 9, 2026, in Molecular Cancer, a scientific journal specializing in cancer research published by UK-based BioMed Central (BMC), Springer Nature.

 Key Findings

 ● Discovery of an immunotherapy-responsive subtype among clear cell ovarian cancers previously considered resistant to anticancer drugs and immunotherapy in both humans and mice

 ● Inflammation-related protein IL-17 directly activates the cancer cells and creates an immune-permissive microenvironment by recruiting immune cells 

 ● These findings may enable prediction of immunotherapy efficacy in individual patients, contributing to the development of personalized medicine

Background of the Study
Ovarian cancer is one of the most difficult cancers to treat among gynecological cancers. Among these, clear cell ovarian cancer accounts for about one-quarter of all ovarian cancers in Japan and is known to be more common here than in Western countries. Because clear cell ovarian cancer is resistant to anticancer drugs and remains challenging to manage after recurrence, new treatment strategies have been urgently needed.

In recent years, cancer immunotherapy (e.g., immune checkpoint inhibitors*3), which harnesses the body’s immune system to attack cancer, has shown promising results in the treatment of various types of cancer. However, large-scale clinical trials have not demonstrated a clear benefit in ovarian cancer. In particular, clear cell ovarian cancer has long been considered an immunologically cold tumor because it contains few surrounding immune cells. Nevertheless, previous studies have reported cases where immunotherapy was highly effective in some patients with clear cell ovarian cancer, highlighting the major challenges of understanding why only certain patients respond and how to identify those who are likely to benefit.

Overview of the Study
First, the research group analyzed tissue samples and genetic data from 180 cases of human clear cell ovarian cancer. The results revealed that, although the number of immune cells in clear cell ovarian cancer is low overall, a very small proportion (approximately 5%) exhibits a subtype in which inflammation-related protein IL-17 is highly active. This type of cancer showed an inflammatory signature, characterized by immune cell infiltration and activation within the tumor microenvironment. Crucially, this characteristic emerged independently of the markers traditionally used to predict the efficacy of immunotherapy, suggesting that IL-17 has the potential to serve as a new biomarker.

Second, we verified the mechanism by which IL-17 functions using a mouse model that replicates human clear cell ovarian cancer and cultured cells. The results revealed that IL-17 acts directly on the cancer cells themselves, triggering the inflammatory switch known as NF-κB*4 within the cells, causing them to release substances that attract and activate immune cells. When an environment conducive to IL-17 action was established in mice, increased infiltration and activation of immune cells were observed within tumors, leading to enhanced efficacy of immunotherapy (anti-PD-L1 antibody) and prolonged survival. These findings indicate that IL-17 acts as a trigger that transforms immunologically cold tumors, into a state in which the immune system can effectively attack cancer cells. Identifying tumors with high IL-17 activity may therefore provide a new biomarker for selecting patients with clear cell ovarian cancer who are likely to benefit from immunotherapy.


Publication
Journal: Molecular Cancer (Impact Factor: 42.2@2025)
Article Title: IL-17–Driven Tumor Cell–Intrinsic Inflammatory Programming Creates an Immunotherapy-Permissive Microenvironment
Authors: Kosuke Murakami1,*, Shiki Takamura2,*, Chiho Miyagawa1, Shiro Takamatsu1, Yoko Kashima1, Koji Nagaoka3, Yukari Kobayashi3, Yoshiyuki Hakata4, Shigeki Kato3, Sachiyo Tsuji-Kawahara3, Ding Nan1, Ronald Chandler5, Satoru Takahashi6, Masaaki Miyazawa3, Kazuhiro Kakimi3, Noriomi Matsumura1  *Contributed equally
Affiliations: 1. Department of Obstetrics and Gynecology, Kindai University Faculty of Medicine,  2. Laboratory for Immunological Memory, RIKEN Center for Integrative Medical Sciences, 3. Department of Immunology, Kindai University Faculty of Medicine, 4. Department of Arts and Sciences, Kindai University Faculty of Medicine, 5. Department of Obstetrics, Gynecology and Reproductive Biology, College of Human Medicine, Michigan State University, 6. Department of Anatomy and Embryology and Laboratory Animal Resource Center in Transborder Medical Research Center, Institute of Medicine, University of Tsukuba,
URL: https://link.springer.com/article/10.1186/s12943-026-02726-2
DOI: https://doi.org/10.1186/s12943-026-02726-2

Details of the Study
Ovarian clear cell carcinoma is characterized by a slightly higher number of CD4-positive T cells*5, a feature that caught the research group’s attention. Analysis of large-scale genomic datasets revealed that a subset of cancers with high IL-17 activity develop an inflammatory state characterized by the recruitment and activation of immune cells. This state emerged independently of conventional biomarkers for predicting treatment response, such as microsatellite instability (MSI※6) and high tumor mutational burden (TMB※6).

Furthermore, the study confirmed that IL-17 acts directly on cancer cells without involving immune cells to activate NF-κB, thereby inducing the production of substances such as chemokines that recruit immune cells. In mouse models, tumors exposed to IL-17 showed increased recruitment and activation of immune cells within the tumor microenvironment. Additionally, single-cell-level analysis revealed that these immune cells were not dysfunctional but retained their ability to attack the tumor. Furthermore, mice with an inflammatory tumor microenvironment showed prolonged survival following treatment with an anti–PD-L1 antibody, whereas no survival difference was observed in the absence of immunotherapy. These results indicate that IL-17 is not a marker of prognosis, but rather a biomarker for predicting the response to immunotherapy.

These findings present new insights that may apply not only to clear cell ovarian cancer but also to a wide range of cancer types, suggesting that the inflammatory environment created by the cancer cells themselves influences the efficacy of immunotherapy.

 

Researcher Commentary
Kosuke Murakami
Affiliation: Department of Obstetrics and Gynecology, Kindai University Faculty of Medicine
Position: Lecturer, Faculty of Medicine
Degree: Doctor of Medicine
Comment: Clear cell ovarian cancer is resistant to anticancer drugs, and immunotherapy has not been accessible to many patients.
Although it represents only a small subset, we have demonstrated that there are indeed cancer types that are highly responsive to immunotherapy, and that inflammation induced by IL-17 is the key factor underlying this response. This achievement was made possible only through close collaboration between RIKEN and the Faculty of Medicine at our university. We hope to further advance our research toward the realization of personalized medicine by identifying patients who are likely to benefit from treatment and delivering the optimal therapy for each individual.

 [Glossary]
*1 IL-17: Interleukin-17. A type of protein (cytokine) involved in inflammation, produced by immune cells and other cells.
*2 Clear cell ovarian cancer: A histological subtype of ovarian cancer. It accounts for approximately one-quarter of ovarian cancer cases in Japanese women and is known for being difficult to treat due to its resistance to anticancer drugs.
*3 Immune checkpoint inhibitors: Drugs that release the “brakes” placed on the immune system by cancer cells, allowing the immune system to attack cancer. Representative examples include anti-PD-1 antibodies and anti-PD-L1 antibodies.
*4 NF-κB: A protein that acts as a command center within cells, simultaneously regulating the activity of many genes involved in inflammation and immunity.
*5 CD4-positive T cells: T cells are central immune cells that attack foreign substances and cancer cells that have invaded the body; they are broadly classified into CD4-positive T cells and CD8-positive T cells.
*6 MSI and TMB: These stand for microsatellite instability and tumor mutational burden, respectively. These are markers that have been used to predict the likelihood of a response to immunotherapy.